002901 大博医疗
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入1,876,25522.69%2,135,5591,533,1211,434,0991,994,334
减:营业总成本1,409,95211.66%1,759,9301,459,1931,369,8421,244,770
    其中:营业成本539,80611.97%667,258492,239333,920311,056
               财务费用(23,875)126.26%(9,286)(23,186)(25,228)(7,816)
               资产减值损失(45,967)64.05%(43,413)(50,141)(12,055)(8,976)
公允价值变动收益37,7143,523.41%3,1095,6021,7711,218
投资收益5,809-49.25%17,2799,74716,20620,189
    其中:对联营企业和合营企业的投资收益--------(120)16
营业利润514,35978.22%429,556103,216147,452822,007
利润总额514,34478.80%428,41499,721147,459802,512
减:所得税费用65,521167.25%43,12213,40537,892111,012
净利润448,82470.56%385,29286,316109,567691,500
减:非控股权益24,1773.88%28,48927,35617,01218,191
股东净利润424,64677.03%356,80358,96192,555673,309

市场价值指针
每股收益 (元) *1.04480.26%0.8600.1400.2201.680
每股派息 (元) *----0.5000.250--0.500
每股净资产 (元) *8.0595.48%7.4377.3877.246--
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容